Aptevo Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 6.83 million compared to net income of USD 2.77 million a year ago. Basic loss per share from continuing operations was USD 9.95 compared to basic earnings per share from continuing operations of USD 11.45 a year ago.

Diluted loss per share from continuing operations was USD 9.95 compared to diluted earnings per share from continuing operations of USD 11.45 a year ago. Basic loss per share was USD 9.95 compared to basic earnings per share of USD 17.38 a year ago. Diluted loss per share was USD 9.95 compared to diluted earnings per share of USD 17.38 a year ago.